Iperten



Indications and Reactions:

Role Indications Reactions
Primary
Product Used For Unknown Indication 42.9%
Rheumatoid Arthritis 28.6%
Hypertension 14.3%
Off Label Use 14.3%
Off Label Use 100.0%
Secondary
Drug Use For Unknown Indication 43.4%
Hypertension 15.4%
Product Used For Unknown Indication 13.7%
Rheumatoid Arthritis 9.1%
Osteoporosis 2.3%
Thrombosis Prophylaxis 2.3%
Dyspepsia 1.7%
Helicobacter Infection 1.7%
Hypothyroidism 1.7%
Type 2 Diabetes Mellitus 1.7%
Diabetes Mellitus 1.1%
Lewis-sumner Syndrome 1.1%
Pulmonary Embolism 1.1%
Venous Thrombosis 1.1%
Erysipelas 0.6%
Gout 0.6%
Onychomycosis 0.6%
Parkinson's Disease 0.6%
Tuberculosis 23.7%
Rhabdomyolysis 15.8%
Congestive Cardiomyopathy 7.9%
Bradycardia 5.3%
Hyponatraemia 5.3%
Loss Of Consciousness 5.3%
Arteriosclerosis Coronary Artery 2.6%
Atrial Fibrillation 2.6%
Balance Disorder 2.6%
Blood Lactic Acid Increased 2.6%
Cardiac Failure 2.6%
Cytolytic Hepatitis 2.6%
Gastrointestinal Haemorrhage 2.6%
Hypotension 2.6%
Motor Dysfunction 2.6%
Nausea 2.6%
Oedema Peripheral 2.6%
Orthostatic Hypotension 2.6%
Presyncope 2.6%
Renal Failure 2.6%
Concomitant
Hypertension 27.4%
Drug Use For Unknown Indication 18.2%
Product Used For Unknown Indication 13.6%
Diabetes Mellitus 4.1%
Atrial Fibrillation 3.7%
Prophylaxis 3.5%
Essential Hypertension 2.8%
Premedication 2.8%
Osteomyelitis 2.5%
Breast Cancer 2.3%
Hepatic Cancer Metastatic 2.1%
Hepatic Neoplasm Malignant 2.1%
Osteoporosis 2.1%
Rheumatoid Arthritis 2.1%
Anaemia 1.8%
Bronchitis 1.8%
Cardiac Disorder 1.8%
Gastric Cancer 1.8%
Hypercholesterolaemia 1.8%
Multiple Myeloma 1.8%
Somnolence 10.0%
Vomiting 8.8%
Renal Failure 7.5%
Hyperkalaemia 6.3%
Hypertension 6.3%
Myalgia 6.3%
Respiratory Failure 6.3%
Diarrhoea 5.0%
Renal Failure Acute 5.0%
Syncope 5.0%
Haemorrhage 3.8%
Hyponatraemia 3.8%
Oedema 3.8%
Sepsis 3.8%
Tachycardia 3.8%
Toxic Epidermal Necrolysis 3.8%
Transaminases Increased 3.8%
Bile Duct Cancer 2.5%
Bursitis Infective Staphylococcal 2.5%
Cholelithiasis 2.5%